Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Financial, travel stocks weigh on FTSE 100; Morrisons drops

Published 04/10/2021, 08:29
Updated 04/10/2021, 16:45
© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo

By Shashank Nayar and Bansari Mayur Kamdar

(Reuters) - London's FTSE 100 index fell on Monday as weakness in financial and travel-linked stocks offset a bounce in energy, while Morrisons dropped after private equity firm Clayton, Dubilier & Rice (CD&R) won a bid for the company.

The blue-chip FTSE 100 index ended 0.2% lower, extending losses for the third straight session, weighed by weakness in financials including HSBC, Prudential (LON:PRU) and Lloyds (LON:LLOY) Group.

Morrisons declined 3.8%, its worst single-day fall since September last year, after U.S. private equity firm CD&R won the auction for Britain's fourth-largest supermarket with a 7 billion pound ($9.5 billion) bid, only marginally above its 285 pence a share offer, already recommended in August.

Peer Sainsbury's rose 3.3% on hopes that SoftBank's Fortress Investment could turn its attention to the company after losing the bidding war for Morrisons.

The domestically focussed mid-cap index fell 1.3%, closing at over a two-month low, led by declines in consumer discretionary stocks.

The FTSE 100 is up nearly 8.5% so far this year on accommodative central bank policies and re-opening optimism.

The index is, however, 2.3% below the highest point hit this year as inflation risks and signs of slowing local and global economic growth have weighed on investor sentiment.

"Inflation continues to underpin market sentiment, with fears over a protracted period of above-target prices bringing expectations of a dramatic rerate in monetary policy expectations," Joshua Mahony, senior analyst at IG Group, said.

"Investors are growing increasingly fearful that the November and December period is characterised by a lack of supply and higher prices."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Limiting further losses were heavyweights BP (LON:BP) and Royal Dutch Shell (LON:RDSa), up 2.1% and 2.2% respectively, tracking a jump in crude prices. [O/R]

Among other stocks, AstraZeneca (NASDAQ:AZN) rose 0.8% after its breast cancer drug, Enhertu, received a breakthrough therapy designation.

Online trading platform Plus500 (LON:PLUSP) rose 1.8% after raising its forecast for the second time in less than three months.

Graphic: Banks shrug off higher yields https://fingfx.thomsonreuters.com/gfx/mkt/xmpjokdajvr/uk%20banks%20oct%204.png

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.